Should You Avoid Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN)?

Page 2 of 2
Company Name # of Hedge Funds # of Insiders Buying # of Insiders Selling
Dendreon Corporation (NASDAQ:DNDN) 12 0 0
China Biologic Products Inc (NASDAQ:CBPO) 2 0 1
Clovis Oncology Inc (NASDAQ:CLVS) 7 0 1
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) 18 1 5
Exelixis, Inc. (NASDAQ:EXEL) 10 1 0

With the returns demonstrated by our time-tested strategies, retail investors should always pay attention to hedge fund and insider trading sentiment, and Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) shareholders fit into this picture quite nicely.

Click here to learn why you should track hedge funds

Page 2 of 2